AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 142 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,036,306 | -50.7% | 475,910 | -14.4% | 0.00% | 0.0% |
Q2 2023 | $6,164,211 | -60.4% | 555,835 | -45.2% | 0.00% | -66.7% |
Q1 2023 | $15,556,842 | -37.3% | 1,013,475 | -9.4% | 0.00% | -50.0% |
Q4 2022 | $24,825,884 | +145.6% | 1,118,787 | +80.8% | 0.01% | +200.0% |
Q3 2022 | $10,107,000 | +279.5% | 618,900 | +237.7% | 0.00% | +100.0% |
Q2 2022 | $2,663,000 | +18.3% | 183,283 | +50.4% | 0.00% | – |
Q1 2022 | $2,251,000 | -14.1% | 121,892 | +10.6% | 0.00% | -100.0% |
Q4 2021 | $2,620,000 | -69.1% | 110,233 | -68.0% | 0.00% | -50.0% |
Q3 2021 | $8,484,000 | +77.1% | 344,479 | +77.7% | 0.00% | +100.0% |
Q2 2021 | $4,791,000 | -39.8% | 193,861 | -46.9% | 0.00% | -50.0% |
Q1 2021 | $7,962,000 | +39.2% | 365,045 | +62.9% | 0.00% | +100.0% |
Q4 2020 | $5,720,000 | +101.0% | 224,144 | +121.7% | 0.00% | 0.0% |
Q3 2020 | $2,846,000 | -34.2% | 101,118 | -33.9% | 0.00% | 0.0% |
Q2 2020 | $4,322,000 | – | 152,941 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
AtonRa Partners | 18,970 | $121,029 | 0.25% |
Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |